THZ1 suppresses human non-small-cell lung cancer cells in vitro through interference with cancer metabolism

[1]  Saman Sadeghi,et al.  Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer. , 2017, Cell reports.

[2]  Giorgio,et al.  Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer , 2016, Oncogene.

[3]  Joan Minguet,et al.  Targeted therapies for treatment of non‐small cell lung cancer—Recent advances and future perspectives , 2016, International journal of cancer.

[4]  Ming-Rong Wang,et al.  Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma , 2016, Gut.

[5]  S. Hanash,et al.  Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. , 2016, Molecular cell.

[6]  J. Albrecht,et al.  Opposing roles of glutaminase isoforms in determining glioblastoma cell phenotype , 2015, Neurochemistry International.

[7]  R. Young,et al.  CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer , 2015, Cell.

[8]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[9]  Agnieszka K. Witkiewicz,et al.  The history and future of targeting cyclin-dependent kinases in cancer therapy , 2015, Nature Reviews Drug Discovery.

[10]  Yan Liu,et al.  Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor. , 2014, Cancer cell.

[11]  Bandana Sharma,et al.  CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer , 2014, Cell.

[12]  Li-Ju Chang,et al.  Hexokinase 2-mediated Warburg effect is required for PTEN- and p53-deficiency-driven prostate cancer growth. , 2014, Cell reports.

[13]  Sridhar Ramaswamy,et al.  Targeting transcription regulation in cancer with a covalent CDK7 inhibitor , 2014, Nature.

[14]  Jennifer B Dennison,et al.  Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer , 2014, Molecular Cancer Therapeutics.

[15]  J. Erickson,et al.  Rho GTPases and their roles in cancer metabolism. , 2013, Trends in molecular medicine.

[16]  K. Bachman,et al.  Analysis of glutamine dependency in non-small cell lung cancer , 2012, Cancer biology & therapy.

[17]  Ge Zhou,et al.  Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells , 2011, Cancer.

[18]  C. Dang,et al.  Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. , 2010, Cancer cell.

[19]  E. Gottlieb,et al.  Targeting metabolic transformation for cancer therapy , 2010, Nature Reviews Cancer.

[20]  Shih-Chieh Lin,et al.  Induction of Pyruvate Dehydrogenase Kinase-3 by Hypoxia-inducible Factor-1 Promotes Metabolic Switch and Drug Resistance* , 2008, Journal of Biological Chemistry.

[21]  R. Deberardinis,et al.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.

[22]  W. Grajkowska,et al.  Relative Expression of mRNAS Coding for Glutaminase Isoforms in CNS Tissues and CNS Tumors , 2008, Neurochemical Research.

[23]  Dirk Eick,et al.  Transcribing RNA Polymerase II Is Phosphorylated at CTD Residue Serine-7 , 2007, Science.

[24]  Nicola Zamboni,et al.  Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells , 2007, The Journal of cell biology.

[25]  Stéphane Larochelle,et al.  Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells. , 2007, Molecular cell.

[26]  R. Deberardinis,et al.  Phosphatidylinositol 3-Kinase-dependent Modulation of Carnitine Palmitoyltransferase 1A Expression Regulates Lipid Metabolism during Hematopoietic Cell Growth* , 2006, Journal of Biological Chemistry.

[27]  Adam L. Meadows,et al.  Estradiol stimulates the biosynthetic pathways of breast cancer cells: detection by metabolic flux analysis. , 2006, Metabolic engineering.

[28]  P. Leder,et al.  Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. , 2006, Cancer cell.

[29]  R. Fisher.  Secrets of a double agent: CDK7 in cell-cycle control and transcription , 2005, Journal of Cell Science.

[30]  D. Guertin,et al.  Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.

[31]  A. Alavi,et al.  Akt Stimulates Aerobic Glycolysis in Cancer Cells , 2004, Cancer Research.

[32]  C. Bondy,et al.  Signaling by insulin-like growth factor 1 in brain. , 2004, European journal of pharmacology.

[33]  J. Lis,et al.  Coordination of transcription, RNA processing, and surveillance by P-TEFb kinase on heat shock genes. , 2004, Molecular cell.

[34]  O. Kaplan.  Correspondence re: M. Fanciulli et al., Energy metabolism of human LoVo colon carcinoma cells: correlation to drug resistance and influence fo lonidamine. Clin. Cancer Res., 6: 1590-1597, 2000. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[35]  T. Bruno,et al.  Energy metabolism of human LoVo colon carcinoma cells: correlation to drug resistance and influence of lonidamine. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  E. Rofstad,et al.  High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. , 2000, Cancer research.

[37]  W. Souba,et al.  Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing. , 1999, Physiological genomics.

[38]  C. Ho,et al.  Distinct roles for CTD Ser-2 and Ser-5 phosphorylation in the recruitment and allosteric activation of mammalian mRNA capping enzyme. , 1999, Molecular cell.

[39]  W. Souba,et al.  Adaptive alterations in cellular metabolism with malignant transformation. , 1998, Annals of surgery.

[40]  J. Portais,et al.  Glucose and glutamine metabolism in C6 glioma cells studied by carbon 13 NMR. , 1996, Biochimie.

[41]  R. Kobayashi,et al.  Molecular cloning of CDK7-associated human MAT1, a cyclin-dependent kinase-activating kinase (CAK) assembly factor. , 1995, Cancer research.

[42]  T. Stossel,et al.  Enhanced motility in NIH 3T3 fibroblasts that overexpress gelsolin. , 1991, Science.

[43]  K. Brand.  Glutamine and glucose metabolism during thymocyte proliferation. Pathways of glutamine and glutamate metabolism. , 1985, The Biochemical journal.

[44]  H. Eagle,et al.  The growth response of mammalian cells in tissue culture to L-glutamine and L-glutamic acid. , 1956, The Journal of biological chemistry.

[45]  O. Warburg,et al.  IRON, THE OXYGEN-CARRIER OF RESPIRATION-FERMENT. , 1925, Science.